QTERN (saxagliptin/dapagliflozin)

QTERN™ is a fixed dose combination of saxagliptin and dapagliflozin and is indicated in adults aged 18 years and older with type 2 diabetes mellitus1

QTERN(saxagliptin/dapagliflozin) Therapeutic Indications and Posology

Indications

QTERN™, fixed dose combination of saxagliptin and dapagliflozin, is indicated in adults aged 18 years and older with type 2 diabetes mellitus:1

Posology

The recommended dose is one 5 mg saxagliptin/10 mg dapagliflozin tablet once daily.1 To be taken at any time of day with or without food.1 Tablet is to be swallowed whole.1

QTERN™ is not recommended for use in patients with an eGFR <60 ml/min/1.73m2.1

QTERN™ can be used in patients with mild or moderate hepatic impairment. Patients with moderate hepatic impairment should be evaluated prior to initiation and during treatment. This medicinal product is not recommended for use in patients with severe hepatic impairment.1